Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Hedenmalm

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Lakartidningen|November 15, 2008
[Relatively good safety in Swedish phase I trials. A survey of studies reported to the Medical Products Agency during 3 years]Anna Glazer, Karin Hedenmalm
Drug Safety|September 27, 2005
Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reportingKarin Hedenmalm, Eva Samuelsson
European Journal of Clinical Pharmacology|July 24, 2002
Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)Karin Hedenmalm, Olav Spigset
European Journal of Clinical Pharmacology|March 7, 2019
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact studyKarin Hedenmalm, Xavier Kurz, Daniel Morales
Acta Obstetricia Et Gynecologica Scandinavica|May 18, 2004
Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcomeKarin Hedenmalm, Eva Samuelsson, Olav Spigset
European Journal of Clinical Pharmacology|November 15, 2007
The conscientious judgement of a DSMB--statistical stopping rules re-examinedKarin Hedenmalm, Hans Melander, Gunnar Alvan
European Journal of Epidemiology|August 27, 2005
Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives--an approach to specifying ratesEva Samuelsson, Karin Hedenmalm, Ingemar Persson
Pharmacoepidemiology and Drug Safety|June 20, 2006
Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs)Karin Hedenmalm, Anders Sundström, Olav Spigset
Lakartidningen|February 28, 2007
[Axillary vein thrombosis in a young woman with a contraceptive ring. Prothrombin gene mutation a possible connection]Eva Samuelsson, Johan Hultdin, Katarina Groth, et al.
European Journal of Clinical Pharmacology|June 16, 2004
Increased liability of tramadol-warfarin interaction in individuals with mutations in the cytochrome P450 2D6 geneKarin Hedenmalm, Jonatan D Lindh, Juliette Säwe, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Lakartidningen|November 15, 2008
[Relatively good safety in Swedish phase I trials. A survey of studies reported to the Medical Products Agency during 3 years]Anna Glazer, Karin Hedenmalm
Drug Safety|September 27, 2005
Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reportingKarin Hedenmalm, Eva Samuelsson
European Journal of Clinical Pharmacology|July 24, 2002
Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)Karin Hedenmalm, Olav Spigset
European Journal of Clinical Pharmacology|March 7, 2019
Effect of withdrawal of fusafungine from the market on prescribing of antibiotics and other alternative treatments in Germany: a pharmacovigilance impact studyKarin Hedenmalm, Xavier Kurz, Daniel Morales
Acta Obstetricia Et Gynecologica Scandinavica|May 18, 2004
Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcomeKarin Hedenmalm, Eva Samuelsson, Olav Spigset
European Journal of Clinical Pharmacology|November 15, 2007
The conscientious judgement of a DSMB--statistical stopping rules re-examinedKarin Hedenmalm, Hans Melander, Gunnar Alvan
European Journal of Epidemiology|August 27, 2005
Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives--an approach to specifying ratesEva Samuelsson, Karin Hedenmalm, Ingemar Persson
Pharmacoepidemiology and Drug Safety|June 20, 2006
Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs)Karin Hedenmalm, Anders Sundström, Olav Spigset
Lakartidningen|February 28, 2007
[Axillary vein thrombosis in a young woman with a contraceptive ring. Prothrombin gene mutation a possible connection]Eva Samuelsson, Johan Hultdin, Katarina Groth, et al.
European Journal of Clinical Pharmacology|June 16, 2004
Increased liability of tramadol-warfarin interaction in individuals with mutations in the cytochrome P450 2D6 geneKarin Hedenmalm, Jonatan D Lindh, Juliette Säwe, et al.
Pageof 4